Page 2 - Les Meilleurs doctors pour le traitement de cancer du nasopharynx en Turquie - TOP-29 des médecins

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Formé en radio-oncologie à l'Université de Marmara, spécialisé dans les techniques de traitement précis du cancer.

• Spécialisation en radio-oncologie achevée en 2016
• Diplôme de médecine de la Faculté de médecine de l'Université de Marmara
• Exerce à l'hôpital Emsey

Le professeur associé Dr Emrah Eraslan est spécialisé en oncologie médicale, se concentrant sur divers cancers, notamment le cancer du nasopharynx, à l'hôpital Koru Ankara.

• Plus de 15 ans d'expérience en médecine interne et en oncologie médicale
• Formation à l'hôpital de formation et de recherche en oncologie Dr Abdurrahman Yurtaslan d'Ankara
• Publication de nombreux articles contribuant à la recherche en oncologie
• Spécialisation dans les cancers du sein, de la prostate, du poumon et colorectal